Healthy volunteers needed to test new enlicitide tablet forms
NCT ID NCT07481708
First seen Mar 20, 2026 · Last updated Apr 29, 2026 · Updated 4 times
Summary
This study looks at how enlicitide (MK-0616) enters the bloodstream when taken as different tablet forms. Thirty healthy adults will take the drug and have blood samples taken to measure absorption. Researchers will also check for side effects and how well the drug is tolerated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion ( Site 0001)
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.